These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 7530068

  • 1. Hepatitis C virus RNA and anti-N14 antibody levels during interferon alpha therapy for chronic hepatitis C.
    Oketani M, Tanaka K, Sho Y, Maeda E, Miyazaki H, Arima T.
    Intern Med; 1994 Oct; 33(10):588-92. PubMed ID: 7530068
    [Abstract] [Full Text] [Related]

  • 2. Changes in antibody titers to hepatitis C virus following interferon therapy for chronic infection.
    Urushihara A, Sodeyama T, Matsumoto A, Tanaka E.
    J Med Virol; 1994 Apr; 42(4):348-56. PubMed ID: 7519250
    [Abstract] [Full Text] [Related]

  • 3. [Changes in C100-3, and N14 antibodies in patients with chronic hepatitis C treated with interferon].
    Sakurai K, Yagi K, Hanawa Y, Shibuya A, Shibata H, Uchiyama Y, Ohtani H.
    Rinsho Byori; 1994 Feb; 42(2):171-5. PubMed ID: 7511184
    [Abstract] [Full Text] [Related]

  • 4. Quantitative analysis of antibodies to hepatitis C virus during interferon-alpha therapy.
    Yuki N, Hayashi N, Hagiwara H, Takehara T, Katayama K, Kasahara A, Fusamoto H, Kamada T.
    Hepatology; 1993 Jun; 17(6):960-5. PubMed ID: 7685734
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Serum hepatitis C virus (HCV)-RNA and response to alpha-interferon in anti-HCV positive chronic hepatitis.
    Magrin S, Craxì A, Fabiano C, Fiorentino G, Marino L, Almasio P, Pinzello GB, Palazzo U, Vitale M, Maggio A.
    J Med Virol; 1992 Nov; 38(3):200-6. PubMed ID: 1283753
    [Abstract] [Full Text] [Related]

  • 8. Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alfa.
    Tanaka E, Kiyosawa K, Matsumoto A, Kashiwakuma T, Hasegawa A, Mori H, Yanagihara O, Ohta Y.
    Hepatology; 1996 Jun; 23(6):1330-3. PubMed ID: 8675147
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antibodies to hepatitis C virus and hepatitis C virus infection.
    Yuki N, Hayashi N, Kasahara A, Hagiwara H, Fusamoto H, Kamada T.
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():76-9. PubMed ID: 7689512
    [Abstract] [Full Text] [Related]

  • 14. Comparison of quantitative cDNA-PCR with the branched DNA hybridization assay for monitoring plasma hepatitis C virus RNA levels in haemophilia patients participating in a controlled interferon trial.
    Bresters D, Cuypers HT, Reesink HW, Mauser-Bunschoten EP, van den Berg HM, Schaasberg WP, Wilber JC, Urdea MS, Neuwald P, Lelie PN.
    J Med Virol; 1994 Jul; 43(3):262-8. PubMed ID: 7931188
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Significance of hepatic expression of hepatitis C viral antigens in chronic hepatitis C.
    González-Peralta RP, Fang JW, Davis GL, Gish RG, Kohara M, Mondelli MU, Urdea MS, Mizokami M, Lau JY.
    Dig Dis Sci; 1995 Dec; 40(12):2595-601. PubMed ID: 8536518
    [Abstract] [Full Text] [Related]

  • 19. Hepatitis C virus RNA in plasma and blood mononuclear cells in patients with chronic hepatitis C treated with alpha-interferon.
    Ounanian A, Gueddah N, Rolachon A, Thelu MA, Zarski JP, Seigneurin JM.
    J Med Virol; 1995 Feb; 45(2):141-5. PubMed ID: 7775931
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.